Sodium Tanshinone II Sulfonate A Ameliorates Hypoxia-Induced Pulmonary Hypertension

BACKGROUND: Pulmonary hypertension (PH) remains a prevalent disease globally. Sodium tanshinone II sulfonate A (STS) has been used in clinical treatment of PH. AIMS: The aim of the present study was to investigate the effect of sodium STS treatment on hypoxia-induced PH and related mechanisms. METHO...

Descripción completa

Detalles Bibliográficos
Autores principales: Bao, Ya-Ru, Chen, Jing-Wei, Jiang, Yan, Wang, Lin-Hui, Xue, Rong, Qian, Jin-Xian, Zhang, Guo-Xing
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2020
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7253651/
https://www.ncbi.nlm.nih.gov/pubmed/32508639
http://dx.doi.org/10.3389/fphar.2020.00687

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7253651/
https://www.ncbi.nlm.nih.gov/pubmed/32508639
http://dx.doi.org/10.3389/fphar.2020.00687

Ejemplares similares